2018
DOI: 10.3390/biomedicines6010035
|View full text |Cite
|
Sign up to set email alerts
|

VHL and Hypoxia Signaling: Beyond HIF in Cancer

Abstract: Von Hippel-Lindau (VHL) is an important tumor suppressor that is lost in the majority of clear cell carcinoma of renal cancer (ccRCC). Its regulatory pathway involves the activity of E3 ligase, which targets hypoxia inducible factor α (including HIF1α and HIF2α) for proteasome degradation. In recent years, emerging literature suggests that VHL also possesses other HIF-independent functions. This review will focus on VHL-mediated signaling pathways involving the latest identified substrates/binding partners, in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
69
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 96 publications
(70 citation statements)
references
References 111 publications
0
69
0
1
Order By: Relevance
“…In consequence, the stabilized HIFs activate transcription of several target genes (e.g., VEGF, PDGF) that support cell's adaptation to hypoxia. Mutations that inactivate VHL, lead to persistent HIF upregulation and activation of hypoxia-induced genes, regardless of the oxygen status [153].…”
Section: Relevance Of Ciliary Genes In Renal Cancermentioning
confidence: 99%
“…In consequence, the stabilized HIFs activate transcription of several target genes (e.g., VEGF, PDGF) that support cell's adaptation to hypoxia. Mutations that inactivate VHL, lead to persistent HIF upregulation and activation of hypoxia-induced genes, regardless of the oxygen status [153].…”
Section: Relevance Of Ciliary Genes In Renal Cancermentioning
confidence: 99%
“…In sum, our data put forward a relevant role for the GRK2/HuR/HIF1α module in cancer cells and in response to the adrenergic overdrive, regardless of the oxygen status. Enhanced GRK2 expression and S670 phosphorylation status in the given tumor contexts would lead to enhanced HuR functionality, thus, counteracting the canonical HIF protein degradation driven by prolyl hydroxylases [7,9] and recapitulating a pseudo-hypoxic state in normoxia, as a consequence. Besides inducing the angiogenic remodeling of tumoral stroma, GRK2-induced pseudo-hypoxia might favor cancer cell de-differentiation and emergence of cancer stem-like cells.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, in cancerous cells, the HIF signaling pathway can also be regulated by other environmental and intracellular signaling factors in an oxygen-independent manner, via modulation of protein stability, gene transcription, or mRNA binding proteins such as YB-1 and HuR (Human antigen R), which are often up-regulated in tumor contexts thereby leading to enhanced translation of HIF-1α mRNA in normoxic and hypoxic conditions [7][8][9]. HIF-1α is often downstream of the activation of different plasma membrane receptors-triggered signaling pathways, thus linking HIF-1α status to the growth needs of cells [10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Prognostic biomarkers are important for treating clinicians to help mitigate the risk of postoperative recurrence. In the clinic, von Hippel-Lindau (VHL) mutational status is often used as both a prognostic and predictive biomarker for RCC [153], given its role in hypoxia signaling [154]. VHL mutations were found to be significantly associated with well-defined tumor margins (p = 0.013), nodular tumor enhancement (p = 0.021), and gross appearance of intratumoral vascularity (p = 0.018) [155].…”
Section: Kidneysmentioning
confidence: 99%